ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2512

Contribution of the CALLY index at diagnosis to early prediction of all-cause mortality in patients with ANCA-associated vasculitis

Jang Woo Ha1 and Sang-Won Lee2, 1Division of Rheumatology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seodaemun-gu, Seoul, Republic of Korea, 2Yonsei university college of medicine, Seoul, South Korea

Meeting: ACR Convergence 2025

Keywords: ANCA associated vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2504–2523) Vasculitis – ANCA-Associated Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: This study retrospectively investigated whether the initial C-reactive protein (CRP)-albumin-lymphocyte (CALLY) index at diagnosis can contribute to early prediction of all-cause mortality during follow-up in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Methods: This study included 323 patients with AAV. Clinical data at AAV diagnosis and those during follow-up were collected. The CALLY index was calculated using the following equation: serum albumin (g/L) × lymphocyte count (/mm3) / CRP (mg/L) /10,000. The parameter of serum albumin (g/L) of an equation of the CALLY index was corrected by multiplying the measured serum albumin (g/dL) by 10.

Results: The median age was 61.0 years (36.2% male and 63.8% female). The median CALLY index was calculated as 0.48. Of the 323 patients, 45 (13.9%) died during the follow-up period of 53.7 months. In ROC curve analysis, the optimal cut-off of the CALLY index for all-cause mortality was determined as 0.55 (area 0.715). Patients with the CALLY index ≤0.55 at AAV diagnosis had a significantly higher risk for death (relative risk 7.294), and exhibited a significantly lower cumulative patients’ survival rate than those with the CALLY index >0.55. In multivariable Cox proportional hazard analysis, the CALLY index ≤0.55 (hazard ratio [HR] 3.913), age (HR 1.037) and male sex (HR 2.326) were independently associated with all-cause mortality during follow-up in patients with AAV.

Conclusion: This is the first study to demonstrate that the initial CALLY index at diagnosis could be useful in predicting all-cause mortality during follow-up in patients with AAV.

Supporting image 1*Serum albumin (g/L) = serum albumin (g/dL) × 10

AAV: ANCA-associated vasculitis; ANCA: antineutrophil cytoplasmic antibody; BMI: body mass index; MPA: microscopic polyangiitis; GPA: granulomatosis with polyangiitis; EGPA: eosinophilic granulomatosis with polyangiitis; MPO: myeloperoxidase; P: perinuclear; PR3: proteinase 3; C: cytoplasmic; BVAS: the Birmingham vasculitis activity score; FFS: the five-factor score; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; CALLY: C-reactive protein-albumin-lymphocyte.

Supporting image 2Fig. 1 Relative risk of the initial CALLY index for all-cause mortality

(A) The cut-off of the CALLY index was determined as 0.55 using ROC curve analysis. (B) Patients with the CALLY index ≤0.55 at AAV diagnosis had a higher risk for death than those without.

CALLY: C-reactive protein-albumin-lymphocyte; ROC: receiver operating characteristic; AAV: ANCA-associated vasculitis; ANCA: antineutrophil cytoplasmic antibody; RR: relative risk; CI: confidence interval.

Supporting image 3Fig. 2 Cumulative survival rates

Patients with the CALLY index ≤0.55 at AAV diagnosis exhibited a significantly lower cumulative patients’ survival rate than those without.

CALLY: C-reactive protein-albumin-lymphocyte; AAV: ANCA-associated vasculitis; ANCA: antineutrophil cytoplasmic antibody.


Disclosures: J. Ha: Samsung Bioepis, 5; S. Lee: None.

To cite this abstract in AMA style:

Ha J, Lee S. Contribution of the CALLY index at diagnosis to early prediction of all-cause mortality in patients with ANCA-associated vasculitis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/contribution-of-the-cally-index-at-diagnosis-to-early-prediction-of-all-cause-mortality-in-patients-with-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contribution-of-the-cally-index-at-diagnosis-to-early-prediction-of-all-cause-mortality-in-patients-with-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology